03:50 AM EST, 02/28/2025 (MT Newswires) -- Michael J. LaBarre, Senior Vice President and Chief Technical Officer, on February 25, 2025, sold 21,697 shares in Halozyme Therapeutics ( HALO ) for $1,260,681. Following the Form 4 filing with the SEC, LaBarre has control over a total of 173,756 common shares of the company, with 173,756 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588925005899/xslF345X05/form4-02272025_110233.xml